Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104506-24-000033
Filing Date
2024-10-31
Accepted
2024-10-31 07:00:05
Documents
89
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q insm-20240930.htm   iXBRL 10-Q 1449861
2 EX-31.1 insm-20240930ex311.htm EX-31.1 9229
3 EX-31.2 insm-20240930ex312.htm EX-31.2 9057
4 EX-32.1 insm-20240930ex321.htm EX-32.1 6330
5 EX-32.2 insm-20240930ex322.htm EX-32.2 5678
  Complete submission text file 0001104506-24-000033.txt   8503789

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT insm-20240930.xsd EX-101.SCH 54841
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT insm-20240930_cal.xml EX-101.CAL 75511
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT insm-20240930_def.xml EX-101.DEF 364811
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT insm-20240930_lab.xml EX-101.LAB 710572
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT insm-20240930_pre.xml EX-101.PRE 565292
92 EXTRACTED XBRL INSTANCE DOCUMENT insm-20240930_htm.xml XML 1122108
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30739 | Film No.: 241412371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)